When apabetalone becomes the next best thing in biotech, almost no one will think or remember or know that it took 20 some years of R&D to develop.  They won't know or care who DM is.  They won't wonder why it was or wasn't on the NASDAQ.  They probably won't even know that it came out of Canada.  The only thing anyone will remember is that you could have bought this stock for 0.80Cdn in 2020 before the company was bought by a major pharmaceutical in 2022 for $50/share and how some people who were 'in the know' made an absolute killing on it.  And yes, even those retail naysayers (who ended up laughing all the way to the bank btw) will be telling everyone that they knew all along that this was a slam dunk.  If it's one thing an epigenetic pill can't alter, its human nature.